EMPIRICO Trademark

Trademark Overview

On Friday, August 25, 2023, a trademark application was filed for EMPIRICO with the United States Patent and Trademark Office. The USPTO has given the EMPIRICO trademark a serial number of 98151684. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, October 22, 2024. This trademark is owned by Empirico Inc.. The EMPIRICO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for preventing or treating diseases of the cardiovascular system, diseases of the endocrine system, diseases of the gastrointestinal and digestive system, diseases of aging, diseases of the blood, diseases of the brain, diseases of the ear, nose and throat, diseases of the liver, diseases of the kidney, diseases of the nervous system, cancer, metabolic diseases, diseases of the immune system, diseases of the respiratory system, diseases of the musculoskeletal system, diseases of the genitourinary system, diseases of the skin, diseases of the eye, diseases of the auditory system, diseases of the reproductive system, diseases of pregnancy, psychiatric diseases, nutritional diseases, hereditary diseases, allergic diseases and infectious diseases; pharmaceutical preparations for use in angiology, cardiology, endocrinology, gastroenterology, genetics, geriatrics, gynecology, hematology, hepatology, immunology, nephrology, neurology, obstetrics, oncology, pulmonol...
empirico

General Information

Serial Number98151684
Word MarkEMPIRICO
Filing DateFriday, August 25, 2023
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, October 22, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 27, 2024

Trademark Statements

Goods and ServicesPharmaceutical preparations for preventing or treating diseases of the cardiovascular system, diseases of the endocrine system, diseases of the gastrointestinal and digestive system, diseases of aging, diseases of the blood, diseases of the brain, diseases of the ear, nose and throat, diseases of the liver, diseases of the kidney, diseases of the nervous system, cancer, metabolic diseases, diseases of the immune system, diseases of the respiratory system, diseases of the musculoskeletal system, diseases of the genitourinary system, diseases of the skin, diseases of the eye, diseases of the auditory system, diseases of the reproductive system, diseases of pregnancy, psychiatric diseases, nutritional diseases, hereditary diseases, allergic diseases and infectious diseases; pharmaceutical preparations for use in angiology, cardiology, endocrinology, gastroenterology, genetics, geriatrics, gynecology, hematology, hepatology, immunology, nephrology, neurology, obstetrics, oncology, pulmonology, pneumology, respirology, rheumatology, anesthesiology, urology, dermatology, gynecology, orthopedics, ophthalmology, infectiology, and psychiatry, particularly for preventing or treating diseases of the cardiovascular system, diseases of the endocrine system, diseases of the gastrointestinal and digestive system, diseases of aging, diseases of the blood, diseases of the brain, diseases of the ear, nose and throat, diseases of the liver, diseases of the kidney, diseases of the nervous system, cancer, metabolic diseases, diseases of the immune system, diseases of the respiratory system, diseases of the musculoskeletal system, diseases of the genitourinary system, diseases of the skin, diseases of the eye, diseases of the auditory system, diseases of the reproductive system, diseases of pregnancy, psychiatric diseases, nutritional diseases, hereditary diseases, allergic diseases and infectious diseases; pharmaceutical preparations for use in pediatric, adolescent, adult, geriatric, inpatient, outpatient, acute, emergency, family, and preventative medicine, particularly for preventing or treating diseases of the cardiovascular system, diseases of the endocrine system, diseases of the gastrointestinal and digestive system, diseases of aging, diseases of the blood, diseases of the brain, diseases of the ear, nose and throat, diseases of the liver, diseases of the kidney, diseases of the nervous system, cancer, metabolic diseases, diseases of the immune system, diseases of the respiratory system, diseases of the musculoskeletal system, diseases of the genitourinary system, diseases of the skin, diseases of the eye, diseases of the auditory system, diseases of the reproductive system, diseases of pregnancy, psychiatric diseases, nutritional diseases, hereditary diseases, allergic diseases and infectious diseases; pharmaceutical preparations for the treatment of infectious, deficiency, excess, acquired, idiopathic, iatrogenic, genetic, hereditary, and physiological diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, September 26, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameEmpirico Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92122
Party NameEmpirico Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92122

Trademark Events

Event DateEvent Description
Tuesday, August 29, 2023NEW APPLICATION ENTERED
Thursday, April 25, 2024ASSIGNED TO EXAMINER
Friday, April 26, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, September 26, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, April 26, 2024NON-FINAL ACTION E-MAILED
Friday, April 26, 2024NON-FINAL ACTION WRITTEN
Wednesday, July 24, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 24, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 24, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, July 25, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 7, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 27, 2024PUBLISHED FOR OPPOSITION
Tuesday, August 27, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 22, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Related Keywords

empirico diseases system preparations pharmaceutical infectious angiology cardiology allergic endocrinology nutritional